Engineering ultra-low-gliadin wheat for celiac disease using an integrated RNAi, CRISPR, and doubled haploid strategy
Journal of Experimental Botany · 2026
DOI: 10.1093/jxb/erag131 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Experimental Botany, 2026. Verfasst von Miriam Marín-Sanz und 6 weiteren Autor:innen. Beteiligte Einrichtung: Functional Genomics Laboratory, Plant Breeding Department, Institute for Sustainable Agriculture, Spanish National Research Council (IAS-CSIC), Av. M…. Hauptthemen laut MEDLINE: Triticum, Gliadin, RNA Interference, Celiac Disease. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Junta de Andalucı́a, Conexión TRIGO, grant number 202490E049)..
Abstract (Originalsprache)
The growing prevalence of gluten-related disorders in humans has driven the development of wheat varieties with reduced immunogenic gluten. This study aimed to integrate RNA interference (RNAi) and CRISPR genome editing within a doubled haploid (DH) platform to overcome challenges of gene redundancy and polyploidy in wheat gliadins. We generated DH lines from crosses between RNAi and CRISPR lines and elite wheat cultivars, enabling stable fixation of multiple genetic modifications in a single generation. Deep sequencing analysis of α-gliadin amplicons was conducted using a custom bioinformatics pipeline optimized for complex, repetitive gene families. Gluten protein profiles were evaluated using RP-HPLC and R5 monoclonal antibody. Several DH lines presented >70% reduction in immunogenic epitopes in α-gliadins, with lines outperforming both parents. Editing frequency was influenced by sgRNA efficiency and parental background. Silencing and editing combined led to nearly depleted gliadins in some lines, often with compensatory increases in other storage proteins linked to bread-making quality, such as high-molecular-weight glutenin subunits. Kernel and specific weight traits were largely maintained. This work demonstrates that combining RNAi and CRISPR in a DH platform enables efficient, heritable reduction of immunogenic gluten, providing a viable strategy for breeding wheat lines safer for individuals with gluten-related disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Functional Genomics Laboratory, Plant Breeding Department, Institute for Sustainable Agriculture, Spanish National Research Council (IAS-CSIC), Av. Menéndez Pidal s/n, Córdoba 14004, Spain.
- Department of Genetics and Plant Breeding, Aula Dei Experimental Station, Spanish National Research Council (EEAD-CSIC), Avda. Montañana 1005, Zaragoza 50059, Spain.
ORCID-Profile: Miriam Marín-Sanz, María H Guzmán-López, Francisco Barro
Förderung
- Junta de Andalucı́a
- Conexión TRIGO, grant number 202490E049).
Zitieren
APA
Marín-Sanz, M., Berlanga-Torres, J. A., Guzmán-López, M. H., Sánchez-León, S., Vallés, M. P., Castillo, A. M., & Barro, F. (2026). Engineering ultra-low-gliadin wheat for celiac disease using an integrated RNAi, CRISPR, and doubled haploid strategy. Journal of Experimental Botany. https://doi.org/10.1093/jxb/erag131
Vancouver
Marín-Sanz M, Berlanga-Torres JA, Guzmán-López MH, Sánchez-León S, Vallés MP, Castillo AM, et al. Engineering ultra-low-gliadin wheat for celiac disease using an integrated RNAi, CRISPR, and doubled haploid strategy. Journal of Experimental Botany. 2026. doi:10.1093/jxb/erag131
BibTeX
@article{MarnSanz2026,
author = {Marín-Sanz, Miriam and Berlanga-Torres, José A and Guzmán-López, María H and Sánchez-León, Susana and Vallés, María P and Castillo, Ana M and Barro, Francisco},
title = {Engineering ultra-low-gliadin wheat for celiac disease using an integrated RNAi, CRISPR, and doubled haploid strategy},
journal = {Journal of Experimental Botany},
year = {2026},
doi = {10.1093/jxb/erag131}
}
EUVIMED